Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    Pierre Arsène, Founder and CEO, Mursla Bio	Dr Tomás Dias, CSO, Mursla Bio
    12 November 2024

    Mursla Bio joins leading European consortium to advance clinical applications based on extracellular vesicle science

    Selected to support scaling and commercialization strategy for extracellular vesicle-based disease surveillance and diagnostics Consortium funded by Horizon Europe, the largest European research and innovation program Cambridge, UK, and Boston, MA, USA: Mursla Bio, a leader in Extr...

    Gary Jennings, Innovation Director, The EpiCentre
    11 November 2024

    The Epicentre launches a new growth accelerator programme to help its occupiers build for their future

    The Epicentre at Haverhill has launched a growth accelerator programme to help its clients’ growth with two unique options to suit startups, R&D spinouts, and established SMEs ...

    Fast 50 winners
    11 November 2024

    Cambridgeshire and East Anglia companies in Deloitte UK Tech Fast 50 ranking

    In a ranking of the UK’s 50 fastest growing technology companies, Halo Service Solutions and bit.bio secure places For a second year running, online blanking platform Allica Bank has topped the UK ranking; ...

    Cambridge event production company
    12 November 2024

    WaveFX transforms Lisbon into a live streaming hub

    WaveFX has just returned from a week in Portugal, filming and live streaming for EACTS (European Association for Cardio-Thoracic Surgery). This prestigious scientific event stands as the largest global gathering for the cardiothoracic community, drawing thousands of delegates from aroun...

    Cambridge Wireless International Conference - March 2025
    8 November 2024

    Answer the call for speakers & start-ups for CW's International Conference

    Don't miss this opportunity to feature as a speaker or to showcase your start-up business at the upcoming Cambridge Wireless International Conference (CWIC), taking place on 27 March 2025 at Hinxton Hall, Cambridgeshire. ...

    image
    7 November 2024

    New technology enhances hearing aid fittings at Hearing Healthcare Centre

    As the prevalence of hearing loss continues to rise, especially in older adults, the demand for innovative and effective solutions has become paramount. Hearing Healthcare Centre understands the critical role of personalised care, making it their mission to incorporate cutting-edge hear...

    Strategies for combination therapy in oncology – Part three: Thinking outside the box
    6 November 2024

    Strategies for combination therapy in oncology – Part three: Thinking outside the box

    This article is published in PM360

     SolasCure and U.S. Army Institute of Surgical Research
    6 November 2024

    SolasCure and U.S. Army Institute of Surgical Research collaborate for combat wound care

    The collaboration will evaluate Aurase Wound Gel for the treatment of infected wounds in combat field care scenarios Cambridge, UK and Texas, USA, 06 November 2024: SOLASCURE Ltd, a biotechnology company developing a novel treatment to transform chronic wound care and the U.S. Army ...

    The economic cost of living with a rare disease across Europe
    21 October 2024

    The economic cost of living with a rare disease across Europe

    Although rare diseases affect a relatively small number of patients, collectively there are an estimated 30 million people in Europe living with 6,000-7,000 known rare diseases (RDs). There is growing recognition of rare diseases as a public health concern, given the many social, mental...

    Price achieved for first indication vs. ASMR
    21 October 2024

    Price achieved for first indication vs. ASMR

    CRA Life Sciences continues its series on leveraging RADAR, its orphan drug data repository, with a focus on PMA trends between ASMR outcomes and average annual treatment costs. The analysis shows a clear correlation between the ASMR rating and the level of price achieved. Notably, ASMR...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 125
    • Page 126
    • Current page 127
    • Page 128
    • Page 129
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS